Sensei Biotherapeutics Reports Second Quarter 2021 Results and Highlights Recent In Vivo Data from SNS-VISTA Program

NEXT STORY
Vaxil Announces Changes to Senior Management and Provides Updates on Current Research and Development Work
PREV STORY
OpGen to Provide Business Update and Financial Results for the Second Quarter 2021 on August 12th at 4:30 p.m. Eastern Time
Subscribe to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Arch Biopartners Announces Issuance of U.S. Patent for Its Novel Antibacterial Drug AB569, Designed to Target Chronic Infection and Antibiotic Resistance

TORONTO, March 27, 2018 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (Arch or the Company) ...

author_avatar
NASDAQ Market News

Number of Shares and Voting Rights of Innate Pharma as of October 1, 2020

author_avatar
NASDAQ Market News

Fennec Pharmaceuticals Announces Amendment to Increase Existing Senior Debt Facility

author_avatar
NASDAQ Market News